Polycystic ovarian changes are defined as the presence of ≥12 immature, small follicles between 2-9 mm in diameter in both ovaries at the time of ultrasound. If the patient does not have mature follicles during the continuous follicular testing and has clinical manifestations such as obesity, hirsutism, acanthosis nigricans, etc., it is necessary to check the sex hormone panel. If the sex hormone test shows that luteinizing hormone is higher than follicular estrogen and the level of androgens is high, it indicates that the patient has polycystic ovary syndrome, and the patient can choose to use Da-Ying-35 or hormonal drugs such as Tocopherol or progesterone to regulate the cycle. If pancreatic resistance is present, metformin can also be added to the treatment.